Elevation Oncology Inc. (ELEV)
NASDAQ: ELEV
· Real-Time Price · USD
0.38
0.06 (18.79%)
At close: Jun 09, 2025, 3:59 PM
Elevation Oncology Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for ELEV stock have an median target of 3, with a low estimate of 0.7 and a high estimate of 7. The median target predicts an increase of 689.47% from the current stock price of 0.38.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 0.7 | 3.62 | 3 | 7 |
| Change | 84.21% | 852.63% | 689.47% | 1742.11% |
Latest Analyst Insight Report
Piper Sandler downgraded Elevation Oncology to Neu... Unlock content with Pro Subscription
Updated Mar 21, 2025
| Rating | Jul 24 | Aug 24 | Dec 24 | Jan 25 | Mar 25 | Jun 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 3 | 2 | 4 | 0 |
| Hold | 0 | 0 | 0 | 0 | 4 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 3 | 2 | 8 | 1 |
Financial Forecast this Year
Revenue This Year
n/a
Revenue Next Year
0
from 0
Increased by n/a%
EPS This Year
-0.67
from -0.78
Increased by 14.1%
EPS Next Year
-0.42
from -0.67
Increased by 37.3%